Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Measurement Nt-proBNP circulating concentrations in heart failure patients with a new point-of-care assay.

Lepoutre T, Rousseau MF, Ahn SA, Gruson D.

Clin Lab. 2013;59(7-8):831-5.

PMID:
24133913
2.

Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.

Januzzi JL Jr, Chen-Tournoux AA, Moe G.

Am J Cardiol. 2008 Feb 4;101(3A):29-38. doi: 10.1016/j.amjcard.2007.11.017. Review.

PMID:
18243855
3.

PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.

Zaninotto M, Mion MM, Di Serio F, Caputo M, Ottomano C, Plebani M.

Clin Chem Lab Med. 2010 Jul;48(7):1029-34. doi: 10.1515/CCLM.2010.222.

PMID:
20406130
4.

Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.

Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK, Fineman JR, Bernstein HS.

Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049. Epub 2011 Dec 22.

5.

Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.

Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS.

Clin Chim Acta. 2007 Nov-Dec;386(1-2):20-4. Epub 2007 Jul 25.

PMID:
17854790
6.

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr.

Am Heart J. 2005 Apr;149(4):744-50.

PMID:
15990762
7.

Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.

Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL Jr.

Am Heart J. 2010 Apr;159(4):532-538.e1. doi: 10.1016/j.ahj.2010.01.005.

PMID:
20362709
8.

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.

Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.

J Am Coll Cardiol. 2007 Mar 20;49(11):1193-202. Epub 2007 Mar 6.

9.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.

10.

Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.

Murray H, Cload B, Collier CP, Sivilotti ML.

CJEM. 2006 Jul;8(4):251-8.

PMID:
17324304
11.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

12.

Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.

Bettencourt P, Januzzi JL Jr.

Am J Cardiol. 2008 Feb 4;101(3A):67-71. doi: 10.1016/j.amjcard.2007.11.026. Review.

PMID:
18243862
13.

High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

Bruins S, Fokkema MR, Römer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA.

Clin Chem. 2004 Nov;50(11):2052-8. Epub 2004 Sep 2.

14.

Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.

Noveanu M, Breidthardt T, Potocki M, Reichlin T, Twerenbold R, Uthoff H, Socrates T, Arenja N, Reiter M, Meissner J, Heinisch C, Stalder S, Mueller C.

Crit Care. 2011;15(1):R1. doi: 10.1186/cc9398. Epub 2011 Jan 5.

15.

Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.

Tsutamoto T, Sakai H, Nishiyama K, Tanaka T, Fujii M, Yamamoto T, Horie M.

Circ J. 2007 Dec;71(12):1873-8.

16.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
17.

Analytical performances and heart failure research of the BNP and NT-proBNP assays on the Cobas E601 and ADVIA Centaur.

Zhang X, Wang W, Wang Q, Yang Y, Wen D, Yang Z, Lan H, Li F, Ouyang N, Kan L, Suo M, Yan H.

Clin Lab. 2013;59(7-8):715-25.

PMID:
24133898
18.

Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.

Masson S, Latini R.

Am J Cardiol. 2008 Feb 4;101(3A):56-60. doi: 10.1016/j.amjcard.2007.11.024. Review.

PMID:
18243860
19.

NT-proBNP and BNP: biomarkers for heart failure management.

Bettencourt P.

Eur J Heart Fail. 2004 Mar 15;6(3):359-63.

20.

Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.

Lin CW, Zeng XL, Zhang JF, Meng XH.

J Card Fail. 2014 Mar;20(3):168-73. doi: 10.1016/j.cardfail.2013.12.013. Epub 2013 Dec 19.

PMID:
24361777
Items per page

Supplemental Content

Write to the Help Desk